{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T04:53:12Z","timestamp":1792385592518,"version":"4.4.0"},"reference-count":61,"publisher":"BMJ","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart Asia"],"accepted":{"date-parts":[[2012,1,19]]},"published-print":{"date-parts":[[2012]]},"abstract":"<jats:p>Increasing myocardial contractility has long been considered a big help for patients with systolic heart failure, conferring an augmented haemodynamic profile in terms of higher cardiac output, lower cardiac filling pressure and better organ perfusion. Though concerns have been raised over the safety issues regarding the clinical trials of different inotropes in hearts with systolic dysfunction, they still stand as a main therapeutic strategy in many centres dealing with such patients. They must be used as short in duration, low in dose and stopped as early as possible. Evidence-based guidelines have provided clinicians with valuable data for better applying inotropes in heart failure patients. In this paper, the authors address clinical trials with different agents used for increasing cardiac contractility in heart failure patients. Furthermore, the authors focus on recent guidelines on making the most out of inotropes in heart failure patients.<\/jats:p>","DOI":"10.1136\/heartasia-2011-010068","type":"journal-article","created":{"date-parts":[[2013,4,9]],"date-time":"2013-04-09T17:17:02Z","timestamp":1365527822000},"page":"16-22","source":"Crossref","is-referenced-by-count":12,"title":["Positive inotropes in heart failure: a review article"],"prefix":"10.1136","volume":"4","author":[{"given":"Ahmad","family":"Amin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Maleki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2012,3,2]]},"reference":[{"key":"2025090722321385000_4.1.16.1","doi-asserted-by":"crossref","unstructured":"Gheorghiade M Filippatos GS Felker GM . Diagnosis and Management of Acute Heart Failure Syndromes. 9th edn. Philadelphia: WB Saunders, Braunwald's Heart Dis\u2014A Textbook Cardiovasc Med. Chapter 27. 2011.","DOI":"10.1016\/B978-1-4377-0398-6.00027-5"},{"key":"2025090722321385000_4.1.16.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)09455-2"},{"key":"2025090722321385000_4.1.16.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(97)80012-9"},{"key":"2025090722321385000_4.1.16.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(99)70108-0"},{"key":"2025090722321385000_4.1.16.5","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(86)90475-8"},{"issue":"Suppl II","key":"2025090722321385000_4.1.16.6","first-page":"38","article-title":"Intermittent dobutamine in ambulatory outpatients with chronic cardiac failure (abstract)","volume":"74","author":"Dies","year":"1986","journal-title":"Circulation"},{"key":"2025090722321385000_4.1.16.7","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehn309"},{"key":"2025090722321385000_4.1.16.8","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.cardfail.2009.10.016","article-title":"Renoprotective and potassium Sparing effects of low dose dopamine in acute decompensated heart failure: preliminary results of the dopamine in acute decompensated heart failure (DAD-HF) trial","volume":"15","author":"Giamouzis","year":"2009","journal-title":"J Card Fail"},{"key":"2025090722321385000_4.1.16.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2010.07.246"},{"key":"2025090722321385000_4.1.16.10","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.737106"},{"key":"2025090722321385000_4.1.16.11","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1097\/00003246-199422120-00006","article-title":"Renal support in critically ill patients: low-dose dopamine or low-dose dobutamine?","volume":"22","author":"Duke","year":"1994","journal-title":"Crit Care Med"},{"key":"2025090722321385000_4.1.16.12","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1016\/j.cardfail.2010.06.394","article-title":"Beta-Blocker pretreatment does not affect the renoprotective effects of low-dose dopamine in patients with acute decompensated heart failure","volume":"16","author":"Giamouzis","year":"2010","journal-title":"J Card Fail"},{"key":"2025090722321385000_4.1.16.13","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/j.1875-9114.1986.tb03492.x","article-title":"Pharmacology and therapeutic use of low-dose dopamine","volume":"6","author":"Dasta","year":"1986","journal-title":"Pharmacotherapy"},{"key":"2025090722321385000_4.1.16.14","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.78.3.285"},{"key":"2025090722321385000_4.1.16.15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)10488-8"},{"key":"2025090722321385000_4.1.16.16","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199512000-00004"},{"key":"2025090722321385000_4.1.16.17","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200002000-00013"},{"key":"2025090722321385000_4.1.16.18","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/oxfordjournals.bmb.a070031","article-title":"Peripheral vascular effects of noradrenaline, isopropylnoradrenaline and dopamine","volume":"19","author":"Allwood","year":"1963","journal-title":"Br Med Bull"},{"key":"2025090722321385000_4.1.16.19","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199903000-00049"},{"key":"2025090722321385000_4.1.16.20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0907118"},{"key":"2025090722321385000_4.1.16.21","doi-asserted-by":"crossref","unstructured":"Troitzsch D Abdul-Khaliq H Vogt S . Critical care. 2001;5(Suppl B):P6.","DOI":"10.1186\/cc999"},{"key":"2025090722321385000_4.1.16.22","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(97)00284-1"},{"key":"2025090722321385000_4.1.16.23","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(96)90315-4"},{"key":"2025090722321385000_4.1.16.24","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(99)00461-0"},{"key":"2025090722321385000_4.1.16.25","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)02968-6"},{"key":"2025090722321385000_4.1.16.26","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.12.1541"},{"key":"2025090722321385000_4.1.16.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.03.051"},{"key":"2025090722321385000_4.1.16.28","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(98)00077-1"},{"key":"2025090722321385000_4.1.16.29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199111213252103"},{"key":"2025090722321385000_4.1.16.30","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1161\/01.CIR.82.3.774","article-title":"Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure. Lack of benefit compared with placebo. Enoximone Multicenter Trial Group","volume":"82","author":"Uretsky","year":"1990","journal-title":"Circulation"},{"key":"2025090722321385000_4.1.16.31","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200701000-00021"},{"key":"2025090722321385000_4.1.16.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcts.2007.02.019"},{"key":"2025090722321385000_4.1.16.33","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.18.2222"},{"key":"2025090722321385000_4.1.16.34","doi-asserted-by":"publisher","DOI":"10.1001\/jama.297.17.1883"},{"key":"2025090722321385000_4.1.16.35","unstructured":"Packer M Colucci WS Fisher L . REVIVE II: Multicenter Placebo-Controlled Trial Of Levosimendan On Clinical Status In Acutely Decompensated Heart Failure. Dallas, TX: American Heart Association Scientific Sessions, 2005."},{"key":"2025090722321385000_4.1.16.36","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.76.3.223"},{"key":"2025090722321385000_4.1.16.37","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199307153290301"},{"key":"2025090722321385000_4.1.16.38","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199812173392503"},{"key":"2025090722321385000_4.1.16.39","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198802113180606"},{"key":"2025090722321385000_4.1.16.40","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0735-1097(96)00151-9","article-title":"Cellular basis for improved left ventricular pump function after digoxin therapy in experimental left ventricular failure","volume":"28","author":"McMahon","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"2025090722321385000_4.1.16.41","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/0735-1097(93)90403-N","article-title":"Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group","volume":"22","author":"Uretsky","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"2025090722321385000_4.1.16.42","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199307013290101"},{"key":"2025090722321385000_4.1.16.43","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199702203360801"},{"key":"2025090722321385000_4.1.16.44","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.7.871"},{"key":"2025090722321385000_4.1.16.45","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehi687"},{"key":"2025090722321385000_4.1.16.46","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021266"},{"key":"2025090722321385000_4.1.16.47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejheart.2008.07.007"},{"key":"2025090722321385000_4.1.16.48","unstructured":"Bersten AD Soni N . Pharmacologic Consideration. Oh's Intensive Care Manual. 6th edn. UK: Butterworth-Heinemann, 2009:929."},{"key":"2025090722321385000_4.1.16.49","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2010.05.034"},{"key":"2025090722321385000_4.1.16.50","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1097\/00003246-199111000-00016","article-title":"Experience with phenylephrine as a component of the pharmacologic support of septic shock","volume":"19","author":"Gregory","year":"1991","journal-title":"Crit Care Med"},{"key":"2025090722321385000_4.1.16.51","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1994.03520170064037"},{"key":"2025090722321385000_4.1.16.52","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.192065"},{"key":"2025090722321385000_4.1.16.53","doi-asserted-by":"crossref","first-page":"4A","DOI":"10.1016\/j.amjcard.2006.11.025","article-title":"Review of current and investigational pharmacologic agents for acute heart failure syndromes","volume":"99","author":"Shin","year":"2007","journal-title":"Am J Cardiol"},{"key":"2025090722321385000_4.1.16.54","first-page":"e134","article-title":"HFSA 2010 compr heart fail pract guideline: section 12: eval manag patients acute decompensated","volume":"16","author":"Lindenfeld","year":"2010","journal-title":"Heart Fail J Card Fail"},{"key":"2025090722321385000_4.1.16.55","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.96.4.1165"},{"key":"2025090722321385000_4.1.16.56","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.13.1625"},{"key":"2025090722321385000_4.1.16.57","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.3.348"},{"key":"2025090722321385000_4.1.16.58","doi-asserted-by":"publisher","DOI":"10.1001\/jama.298.4.458"},{"key":"2025090722321385000_4.1.16.59","doi-asserted-by":"publisher","DOI":"10.1054\/jcaf.2001.26655"},{"key":"2025090722321385000_4.1.16.60","doi-asserted-by":"publisher","DOI":"10.1136\/heart.89.6.621"},{"key":"2025090722321385000_4.1.16.61","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-5922.2008.00050.x"}],"container-title":["Heart Asia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartasia-2011-010068","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T05:33:28Z","timestamp":1757309608000},"score":1,"resource":{"primary":{"URL":"https:\/\/heartasia.bmj.com\/lookup\/doi\/10.1136\/heartasia-2011-010068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2012,3,2]]},"published-print":{"date-parts":[[2012]]}},"alternative-id":["10.1136\/heartasia-2011-010068"],"URL":"https:\/\/doi.org\/10.1136\/heartasia-2011-010068","relation":{},"ISSN":["1759-1104"],"issn-type":[{"value":"1759-1104","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}